MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Closed-Loop Spinal Cord Stimulation: A Case Report on a Novel Therapeutic Approach for Post-Hypoxic Myoclonus

A. Patel, L. Venkatesan (Trevose, USA)

Meeting: 2024 International Congress

Abstract Number: 1486

Keywords: Myoclonus: Treatment, Neurostimulation

Category: Myoclonus

Objective: To present a case-study on use of closed-loop spinal cord stimulation (CL-SCS) for treating post-hypoxic myoclonus.

Background: Post-hypoxic myoclonus is severely disabling and can be refractory to conventional medical management. Limited information is available on use of SCS for treatment of this rare delayed movement disorder. Here, we report on use of novel CL-SCS technology in treatment of myoclonus with comorbid chronic pain in the upper extremities.

Method: An 88-year-old Caucasian female presented with hypertension, mild dementia, right carotid stenosis post-endarterectomy, right frontal lobe ischemic stroke with persistent left-sided deficits in 2021 and right-sided cervical radiculopathy in 2023.  The patient experienced post-hypoxic myoclonus after an ischemic stroke. The patient reported severe right-sided neck and upper extremity pain, indicative of right C5 and C6 radiculopathy in early 2023. Cervical MRI confirmed the presence of moderate right-sided neuroforaminal stenosis without significant central stenosis.

Results: Patient was refractory to conventional medical management including C7-T1 right-sided interlaminar epidural steroid injections. A successful 7-day spinal cord stimulation CL-SCS trial to treat her chronic radiculopathy resulted in > 75% neck and right upper extremity pain relief and myoclonus symptom improvement. Permanent CL-SCS implantation resulted in sustained pain relief (>80%), decreased myoclonus frequency/severity (80-85% reduction), and significant improvement in activities of daily living (ADLs) at the 3-month follow-up visit. Objective CL-SCS therapy performance metrics including amount of dorsal column fiber activation and activation accuracy were collected during the follow-up visits.

Conclusion: Although preliminary, closed-loop SCS significantly improved symptoms of stroke induced post-hypoxic myoclonus. Closed-loop SCS consistently activates primary sensory Ab neurons in the spinal cord. This may indirectly deter altered central processing of nociceptive stimuli and dysfunction in the supraspinal neurotransmission system involving subcortical structures like the basal ganglia nuclei.

To cite this abstract in AMA style:

A. Patel, L. Venkatesan. Closed-Loop Spinal Cord Stimulation: A Case Report on a Novel Therapeutic Approach for Post-Hypoxic Myoclonus [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/closed-loop-spinal-cord-stimulation-a-case-report-on-a-novel-therapeutic-approach-for-post-hypoxic-myoclonus/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/closed-loop-spinal-cord-stimulation-a-case-report-on-a-novel-therapeutic-approach-for-post-hypoxic-myoclonus/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley